Lisa Foo Sells 24,000 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THCGet Free Report) EVP Lisa Foo sold 24,000 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $266.32, for a total value of $6,391,680.00. Following the completion of the sale, the executive vice president directly owned 8,053 shares of the company’s stock, valued at $2,144,674.96. This represents a 74.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Tenet Healthcare Trading Down 2.7%

NYSE:THC opened at $258.79 on Thursday. The stock has a market capitalization of $20.84 billion, a price-to-earnings ratio of 9.98, a PEG ratio of 1.01 and a beta of 1.23. Tenet Healthcare Corporation has a 1 year low of $157.58 and a 1 year high of $283.05. The stock has a fifty day moving average price of $234.93 and a two-hundred day moving average price of $210.62. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41.

Tenet Healthcare (NYSE:THCGet Free Report) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter last year, the firm posted $4.02 EPS. The business’s revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare Corporation will post 21.04 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Tenet Healthcare during the second quarter worth $5,504,000. California State Teachers Retirement System lifted its position in Tenet Healthcare by 18,362.2% during the second quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock worth $3,533,142,000 after buying an additional 18,783,432 shares during the period. Compass Financial Management LLC purchased a new stake in Tenet Healthcare in the 2nd quarter valued at about $57,000. AlphaGrep UK Ltd acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at about $344,000. Finally, BAM Wealth Management LLC boosted its position in shares of Tenet Healthcare by 73.1% in the second quarter. BAM Wealth Management LLC now owns 2,421 shares of the company’s stock worth $453,000 after acquiring an additional 1,022 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

THC has been the topic of several research reports. UBS Group upped their target price on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday, July 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research note on Monday, July 27th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, August 23rd. Raymond James Financial reiterated an “outperform” rating and issued a $285.00 price target on shares of Tenet Healthcare in a research report on Friday, August 14th. Finally, Guggenheim raised their price objective on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a research note on Tuesday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $273.00.

Read Our Latest Stock Analysis on Tenet Healthcare

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

See Also

Insider Buying and Selling by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.